CPT1A/2-Mediated FAO Enhancement—A Metabolic Target in Radioresistant Breast Cancer
Shujun Han(Xi'an Jiaotong University), Jian Jian Li(University of California Davis Medical Center), Yinsheng Wang(University of California, Riverside), Ashley Chen-Ping Butler(University of California, Davis), Xiaodi Zhang(Brigham and Women's Hospital), Andrew Vaughan(University of California, Davis), Weili Miao(Wuhan Wudong Hospital), Nian Jiang(University of Minnesota), Matthew A. Coleman(University of California, Davis), Lu Zhang(Qingdao University of Science and Technology), Jie Huang(Menlo School), Ming Fan(University of California, Davis), Bowen Xie(University of California, Davis), Ryan Wei(Temple University), Hong-Wu Chen(University of California, Davis), Jiankang Liu(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 169
Related Papers
ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment
|Proceedings of the National Academy of Sciences|2020|595
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
|Journal of Clinical Oncology|2019|590
Anomalous diffusion modeling by fractal and fractional derivatives
|Computers & Mathematics with Applications|2009|518
Thirdhand Tobacco Smoke: Emerging Evidence and Arguments for a Multidisciplinary Research Agenda
|Environmental Health Perspectives|2011|449
Graphene as a Novel Matrix for the Analysis of Small Molecules by MALDI-TOF MS
|Analytical Chemistry|2010|396